| Application no. and date | 11173336.6 (espacenet) (Federated) (European Patent Register), 20070814 | | Patent/reg. no. and date | DK/EP 2383297, 20130116 | | Publication date | 20111102 | | Priority no. and date | US 822362 P, 20060814 | | EP pub. no. and date |
EP 2383297 20111102 | | Effective date | | | Applicant/owner | Xencor, Inc., 465 North Halstead Street
Suite 200
Pasadena, CA 91107, US | | Applicant ref. no. | P19954DKEP | | Inventor | KARKI, Sher Bahadur, 2833 Providence Way
Pomona, CA 91767, US,
Bernett, Matthew J., 222 E. Olive Ave. 3
Monrovia, CA 91016, US,
Chu, Seung Yup, 4613 Larwin Avenue
Cypress, CA 90630, US,
Desjarlais, John R., 1030 N. Michigan Avenue
Pasadena, CA 91104, US,
Lazar, Gregory Alan, 750 Arcadia Avenue, 6
Arcadia, CA 91007, US,
Pong, Erik WeiKing, 9415 Lemon Avenue
Temple City, CA 91780, US,
Richards, John O., 893 San Marcus Lane
Duarte, CA 91010, US,
Zhukovsky, Eugene Alexander, 1124 N. Kings Road, Apt. 203
West Hollywood, CA 90069, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C, DK | | Opponent | | | IPC Class | C07K 16/28 (2006.01) , C07K 16/46 (2006.01) , C12N 15/13 (2006.01) | | Title | Optimerede antistoffer rettet mod CD19 | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2022 00007 | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
